Xavier Reveles
Chief Operating Officer at BIOAFFINITY TECHNOLOGIES, INC.
Net worth: 43 932 $ as of 2024-06-29
Profile
Xavier T.
Reveles is currently the Director of the Cytogenetics Laboratory at the University of Texas Health Science Center At San Antonio.
He is also a Member of the Association for Molecular Pathology.
Previously, he served as the Laboratory Director at Oncopath Laboratory.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-01-30 | 20,339 ( 0.17% ) | 43 932 $ | 2024-06-29 |
Xavier Reveles active positions
| Companies | Position | Start |
|---|---|---|
| BIOAFFINITY TECHNOLOGIES, INC. | Chief Operating Officer | 2016-12-31 |
Association for Molecular Pathology
 Association for Molecular Pathology BiotechnologyHealth Technology The Association for Molecular Pathology develops molecular diagnostics. The American company was founded by Jeffrey Cossman. | Corporate Officer/Principal | - |
| University of Texas Health Science Center At San Antonio | Corporate Officer/Principal | - |
Former positions of Xavier Reveles
| Companies | Position | End |
|---|---|---|
| Oncopath Laboratory | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIOAFFINITY TECHNOLOGIES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Association for Molecular Pathology
Association for Molecular Pathology BiotechnologyHealth Technology The Association for Molecular Pathology develops molecular diagnostics. The American company was founded by Jeffrey Cossman. | Health Technology |
| Oncopath Laboratory |
- Stock Market
- Insiders
- Xavier Reveles
